Chemical inhibitors of ATP-binding cassette, sub-family A member 14 (ABCA14) encompass a variety of molecules that impede the protein's function through distinct mechanisms of action. Verapamil, a calcium channel blocker, can inhibit ABCA14 by hindering the ATP-driven conformational changes necessary for substrate transport across cellular membranes. This disruption can effectively immobilize the transporter in an inactive state. Quercetin, as a naturally occurring flavonoid, can inhibit ABCA14 by either stabilizing an inactive conformation of the protein or by interfering with the ATPase activity, which is crucial for the transport cycle. Similarly, Valspodar and Elacridar work by competitive and non-competitive inhibition, respectively; Valspodar competes with natural substrates of ABCA14, while Elacridar binds to recognition sites on the protein, blocking the transport pathway.
Continuing with this theme, Tariquidar can inhibit ABCA14 by binding to allosteric sites that modulate the transporter's conformation and ATPase activity. Zosuquidar targets the nucleotide-binding domain, impeding the ATP hydrolysis cycle vital to the transporter's activity. Laniquidar interacts with the transmembrane domains to alter the transporter's conformation, which inhibits substrate translocation. On the other hand, Reserpine can inhibit ABCA14 by occupying the substrate-binding pocket, which prevents substrates from accessing the transport pathway. Progesterone interacts with regulatory sites on ABCA14, which can inhibit the ATP hydrolysis and transport cycle. Cyclosporine A directly binds to the ATP-binding site of ABCA14, inhibiting ATP hydrolysis and thereby the transport mechanism. Glibenclamide inhibits ABCA14 by obstructing the ATP-binding cassette sites critical for the catalytic activity that drives substrate transport. Lastly, Rifampicin can inhibit ABCA14 by preferentially binding to the substrate-binding sites or the nucleotide-binding domains, disrupting the transport cycle and effectively inhibiting the protein's function.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Verapamil | 52-53-9 | sc-507373 | 1 g | $367.00 | ||
Verapamil, a calcium channel blocker, can inhibit ATP-binding cassette, sub-family A member 14 (ABCA14) by obstructing ATP-driven conformational changes essential for substrate transport, as ABCA14 is an ATP-dependent transporter. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $108.00 $245.00 $918.00 $49.00 | 33 | |
Quercetin, a flavonoid with various biological activities, can inhibit ABCA14 by stabilizing the protein in a conformation that prevents substrate binding or by interfering with its ATPase activity. | ||||||
Elacridar | 143664-11-3 | sc-207613A sc-207613 sc-207613B sc-207613C sc-207613D | 5 mg 10 mg 50 mg 100 mg 1 g | $96.00 $111.00 $403.00 $515.00 $2555.00 | 19 | |
Elacridar is known to inhibit P-glycoproteins and can similarly inhibit ABCA14 by binding to its substrate recognition sites, preventing substrate-transport interaction. | ||||||
Reserpine | 50-55-5 | sc-203370 sc-203370A | 1 g 5 g | $134.00 $406.00 | 1 | |
Reserpine can inhibit ABCA14 by binding to the substrate-binding pocket, thus preventing substrate access and inhibiting the transport function of the protein. | ||||||
Progesterone | 57-83-0 | sc-296138A sc-296138 sc-296138B | 1 g 5 g 50 g | $20.00 $51.00 $292.00 | 3 | |
Progesterone inhibits ABCA14 as it can interact with the regulatory sites on the protein, influencing the ATP hydrolysis and transport cycle of ABC transporters. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $62.00 $90.00 $299.00 $475.00 $1015.00 $2099.00 | 69 | |
Cyclosporine A, an immunosuppressant, can inhibit ABCA14 by binding to its ATP-binding site, inhibiting ATP hydrolysis, and consequently the transport mechanism. | ||||||
Glyburide (Glibenclamide) | 10238-21-8 | sc-200982 sc-200982A sc-200982D sc-200982B sc-200982C | 1 g 5 g 25 g 100 g 500 g | $45.00 $60.00 $115.00 $170.00 $520.00 | 36 | |
Glibenclamide can inhibit ABCA14 by blocking the ATP-binding cassette sites, leading to the inhibition of the catalytic activity necessary for substrate transport. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $95.00 $322.00 $663.00 $1438.00 | 6 | |
Rifampicin can inhibit ABCA14 by binding preferentially to the substrate-binding sites or the nucleotide-binding domains, interrupting the transport cycle of the protein. |